Immatics N.V.

IMTX Stock Healthcare Biotechnology
$9.43
-0.10 (-1.05%)
Price as of Sep 01, 2026 market close

Performance

1 Month
+4.5%
3 Months
-6.1%
YTD
-10.2%
1 Year
+85.3%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
62.7%
Largest decline max drawdown, since Aug 2025
-28.0%
Risk-adjusted return Sharpe ratio, 1-year
1.29

Own IMTX?

See how IMTX contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.